By Editor , 16 September 2026

Cambridge, Mass. – September 15, 2026 -- Vincere Biosciences has been awarded a $2.7 million Small Business Innovation Research (SBIR) Phase II grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health, to fund IND-enabling development of its USP30 inhibitor for acute kidney injury (AKI).

By Editor , 16 September 2026
Elanco Executives to Address Investors at Morgan Stanley Healthcare Conference

Indianapolis – September 15, 2026 -- Elanco Animal Health Incorporated (NYSE: ELAN) confirmed its leadership team will participate in the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026.

Top executives to field investor questions in fireside chat format

CEO Jeff Simmons, CFO Bob VanHimbergen, and Bobby Modi, executive vice president for U.S. Pet Health and Global Digital Transformation, will join a fireside chat session scheduled for 2:35 p.m. ET on September 15.

By Editor , 16 September 2026
DuPont, Chemours, Corteva Settle NC PFAS Claims for $455 Million

Wilmington, Del. – September 15, 2026 -- DuPont, together with The Chemours Company and Corteva Inc., has agreed to pay $455 million over 15 years to resolve PFAS litigation brought by the State of North Carolina and 11 local entities near the companies' Fayetteville Works facility.

By Editor , 16 September 2026
BioLineRx, Hemispherian to Present GLIX1 Glioblastoma Data at EANO 2026

Tel Aviv and Oslo – September 15, 2026 -- BioLineRx Ltd. (NASDAQ/TASE: BLRX) and Hemispherian AS will present two abstracts on their oncology candidate GLIX1 at the 21st Meeting of the European Association of Neuro-Oncology (EANO 2026) in Rome, Italy, September 24-27, with one abstract selected for oral presentation.

By Editor , 16 September 2026
Labcorp Targets 5-8% Revenue Growth Through 2029 at Investor Day

Burlington, N.C. – September 15, 2026 -- Labcorp (NYSE: LH) reaffirmed its full-year 2026 guidance and unveiled a long-term outlook through 2029 projecting compound annual revenue growth of 5% to 8% and compound annual adjusted earnings per share growth of 8.5% to 11.5%, the company said at its 2026 Investor Day.

By Editor , 16 September 2026
Chemours Settles NC PFAS Litigation for $455 Million Over 15 Years

Wilmington, Del. – September 15, 2026 -- The Chemours Company, along with DuPont de Nemours and Corteva, has agreed to pay $455 million over 15 years to settle PFAS-related litigation brought by the State of North Carolina and 11 local entities near the company's Fayetteville Works facility.

By Editor , 16 September 2026

Rye, N.Y. – September 15, 2026 -- Dunes Point Capital, LP ("DPC") has sold NextGen Security LLC to funds advised by Apax Partners LLP, exiting an electronic security integrator that operates across 8 locations.

NextGen serves regulated facilities across four end markets

Based in Exton, Pennsylvania, NextGen is an end-to-end integrator of electronic security systems for complex and regulated facilities. The company serves industrial, healthcare, education, and commercial end markets through its 8-location footprint.

By Editor , 16 September 2026
Exiger Completes AI-Native Platform Rebuild, Backed by Carlyle, Insight, JMI

Washington – September 15, 2026 -- Exiger has compressed what was estimated as a three-year, $180 million platform overhaul into a four-month, $20 million sprint, launching an AI-native version of its 1Exiger supply chain and trade compliance platform with backing from Carlyle, Insight Partners, and JMI Equity.